X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4733) 4733
Publication (415) 415
Book Review (13) 13
Magazine Article (5) 5
Book / eBook (4) 4
Book Chapter (4) 4
Conference Proceeding (4) 4
Dissertation (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4042) 4042
male (3273) 3273
female (2996) 2996
hepatectomy - adverse effects (2968) 2968
surgery (2737) 2737
middle aged (2661) 2661
index medicus (2526) 2526
aged (2125) 2125
hepatectomy (2070) 2070
adult (2030) 2030
liver neoplasms - surgery (1906) 1906
treatment outcome (1743) 1743
hepatectomy - methods (1420) 1420
gastroenterology & hepatology (1388) 1388
retrospective studies (1277) 1277
liver (1098) 1098
risk factors (1092) 1092
time factors (1028) 1028
hepatic resection (887) 887
carcinoma, hepatocellular - surgery (857) 857
liver neoplasms - secondary (773) 773
liver neoplasms - mortality (768) 768
liver neoplasms - pathology (757) 757
aged, 80 and over (723) 723
transplantation (697) 697
hepatectomy - mortality (695) 695
animals (683) 683
cancer (647) 647
liver resection (607) 607
resection (592) 592
prognosis (551) 551
hepatocellular-carcinoma (528) 528
survival (519) 519
hepatocellular carcinoma (518) 518
medicine & public health (515) 515
colorectal neoplasms - pathology (514) 514
oncology (510) 510
mortality (507) 507
analysis (472) 472
gastroenterology (472) 472
liver - surgery (468) 468
survival rate (461) 461
carcinoma, hepatocellular - pathology (452) 452
liver cancer (440) 440
liver transplantation - adverse effects (437) 437
risk assessment (434) 434
management (424) 424
young adult (420) 420
liver - pathology (416) 416
postoperative complications - etiology (415) 415
disease-free survival (412) 412
carcinoma, hepatocellular - mortality (409) 409
follow-up studies (408) 408
complications (402) 402
adolescent (399) 399
gastroenterology and hepatology (394) 394
recurrence (382) 382
living donors (377) 377
metastasis (369) 369
rats (360) 360
kaplan-meier estimate (359) 359
prospective studies (347) 347
multivariate analysis (345) 345
liver transplantation (344) 344
chemotherapy (337) 337
hepatology (329) 329
morbidity (328) 328
length of stay (326) 326
survival analysis (325) 325
abridged index medicus (322) 322
liver neoplasms - therapy (313) 313
health aspects (309) 309
postoperative complications (305) 305
neoplasm staging (304) 304
experience (298) 298
care and treatment (296) 296
tumors (291) 291
tomography, x-ray computed (287) 287
liver transplantation - methods (286) 286
outcomes (285) 285
liver regeneration (283) 283
original (277) 277
hepatoma (274) 274
chi-square distribution (269) 269
liver diseases - surgery (264) 264
liver neoplasms - drug therapy (254) 254
cirrhosis (253) 253
liver diseases (251) 251
predictive value of tests (250) 250
proportional hazards models (250) 250
risk-factors (249) 249
postoperative complications - epidemiology (242) 242
laparoscopy - adverse effects (238) 238
abdominal surgery (236) 236
liver function tests (230) 230
carcinoma (225) 225
metastases (220) 220
patient selection (217) 217
colorectal cancer (215) 215
liver - blood supply (215) 215
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4337) 4337
French (79) 79
Japanese (77) 77
Russian (77) 77
German (44) 44
Chinese (43) 43
Spanish (17) 17
Hungarian (13) 13
Italian (12) 12
Polish (8) 8
Romanian (8) 8
Danish (7) 7
Czech (5) 5
Ukrainian (4) 4
Bulgarian (3) 3
Icelandic (2) 2
Norwegian (2) 2
Portuguese (2) 2
Croatian (1) 1
Dutch (1) 1
Hebrew (1) 1
Korean (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Surgery: Official Journal of the Society of University Surgeons, Central Surgical Association, and the American Association of Endocrine Surgeons, ISSN 0039-6060, 2014, Volume 156, Issue 5, pp. 1190 - 1196
Journal Article
Journal Article
Annals of Oncology, ISSN 0923-7534, 03/2004, Volume 15, Issue 3, pp. 460 - 466
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 1, pp. 38 - 47
Summary Background Neoadjuvant chemotherapy for unresectable colorectal liver metastases can downsize tumours for curative resection. We assessed the... 
Hematology, Oncology and Palliative Medicine | SURVIVAL | 1ST-LINE TREATMENT | LEUCOVORIN | PLUS IRINOTECAN | ONCOLOGY | BEVACIZUMAB | OXALIPLATIN | FLUOROURACIL | HEPATIC RESECTION | CANCER | CARCINOMA | ras Proteins - genetics | Proto-Oncogene Proteins p21(ras) | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Tomography, Spiral Computed | Liver Neoplasms - chemistry | Hepatectomy | Antibodies, Monoclonal, Humanized | Fluorouracil - therapeutic use | Austria | Leucovorin - adverse effects | Fluorouracil - adverse effects | Time Factors | Antineoplastic Agents - adverse effects | Female | Leucovorin - therapeutic use | Neoadjuvant Therapy | Retrospective Studies | Chemotherapy, Adjuvant | Cetuximab | Liver Neoplasms - secondary | Odds Ratio | Camptothecin - analogs & derivatives | Camptothecin - adverse effects | Camptothecin - therapeutic use | Liver Neoplasms - genetics | Risk Assessment | Liver Neoplasms - drug therapy | Linear Models | Liver Neoplasms - surgery | Proto-Oncogene Proteins - genetics | Treatment Outcome | Receptor, Epidermal Growth Factor - analysis | Magnetic Resonance Imaging | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Proto-Oncogene Proteins B-raf - genetics | Aged | Mutation | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Germany | Organoplatinum Compounds - adverse effects | Index Medicus
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 13, pp. 1344 - 1354
Summary Background There is no standard of care for adjuvant therapy for patients with hepatocellular carcinoma. This trial was designed to assess the efficacy... 
Hematology, Oncology and Palliative Medicine | CLINICAL-PRACTICE GUIDELINES | DIAGNOSIS | LIVER-TRANSPLANTATION | RISK-FACTORS | THERAPY | MANAGEMENT | ONCOLOGY | SAFETY | PREVENTION | RECURRENCE | Catheter Ablation - mortality | South America | Carcinoma, Hepatocellular - mortality | Humans | Middle Aged | Male | Antineoplastic Agents - therapeutic use | Hepatectomy - mortality | Antineoplastic Agents - administration & dosage | Protein Kinase Inhibitors - adverse effects | North America | Young Adult | Carcinoma, Hepatocellular - drug therapy | Time Factors | Aged, 80 and over | Liver Neoplasms - pathology | Catheter Ablation - adverse effects | Chemotherapy, Adjuvant | Europe | Risk Factors | Niacinamide - adverse effects | Niacinamide - therapeutic use | Disease Progression | New Zealand | Protein Kinase Inhibitors - administration & dosage | Intention to Treat Analysis | Niacinamide - analogs & derivatives | Liver Neoplasms - mortality | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Adult | Female | Double-Blind Method | Hepatectomy - adverse effects | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Neoplasm Recurrence, Local | Phenylurea Compounds - therapeutic use | Carcinoma, Hepatocellular - surgery | Liver Neoplasms - surgery | Treatment Outcome | Niacinamide - administration & dosage | Disease-Free Survival | Phenylurea Compounds - administration & dosage | Asia | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Aged | Australia | Antimitotic agents | Liver cancer | Medical colleges | Surgery | Liver | Clinical trials | Hepatoma | Antineoplastic agents
Journal Article
British Journal of Anaesthesia, ISSN 0007-0912, 10/2013, Volume 111, Issue 4, pp. 549 - 563
Antifibrinolytic drugs have become almost ubiquitous in their use during major surgery when bleeding is expected or commonplace. Inhibition of the fibrinolytic... 
hepatectomy | wounds and injuries | antifibrinolytic agents | orthopaedics | post partum haemorrhage | intracranial haemorrhages | cardiac surgical procedures | liver transplantation | postoperative haemorrhage | Intracranial haemorrhages | Postoperative haemorrhage | Cardiac surgical procedures | Wounds and injuries | Antifibrinolytic agents | Hepatectomy | Liver transplantation | Orthopaedics | Post partum haemorrhage | ORTHOTOPIC LIVER-TRANSPLANTATION | ALLOGENEIC BLOOD-TRANSFUSION | CARDIOPULMONARY BYPASS | CORONARY-ARTERY-BYPASS | EPSILON-AMINOCAPROIC ACID | CELL TRANSFUSION | CARDIAC-SURGERY | DOUBLE-BLIND | SUBARACHNOID HEMORRHAGE | ANESTHESIOLOGY | DOSE TRANEXAMIC ACID | Antifibrinolytic Agents - therapeutic use | Blood Loss, Surgical - prevention & control | Neurosurgical Procedures - adverse effects | Aminocaproic Acid - adverse effects | Postoperative Hemorrhage - prevention & control | Humans | Orthopedic Procedures - adverse effects | Postpartum Hemorrhage - drug therapy | Wounds and Injuries - complications | Antifibrinolytic Agents - adverse effects | Cardiac Surgical Procedures - adverse effects | Tranexamic Acid - therapeutic use | Aprotinin - therapeutic use | Tranexamic Acid - adverse effects | Aprotinin - adverse effects | Pregnancy | Hemorrhage - drug therapy | Aminocaproic Acid - therapeutic use | Female | Liver - surgery
Journal Article
Annals of Surgery, ISSN 0003-4932, 04/2015, Volume 261, Issue 4, pp. 619 - 629
Journal Article
Annals of Surgery, ISSN 0003-4932, 11/2009, Volume 250, Issue 5, pp. 856 - 860
Objective: To analyze the results of 6 international surgical centers performing laparoscopic major liver resections. Summary Background Data: The safety and... 
SURGERY | Hepatectomy - methods | Hepatectomy - adverse effects | Humans | Middle Aged | Male | Liver Neoplasms | Contraindications | Young Adult | Laparoscopy - methods | Intraoperative Complications | Laparoscopy - adverse effects | Adolescent | Aged, 80 and over | Adult | Female | Aged | Postoperative Complications
Journal Article